Net Cash Provided by (Used in) Operating Activities in USD of HAEMONETICS CORP from 2009 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
HAEMONETICS CORP quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2009 to Q2 2025.
  • HAEMONETICS CORP Net Cash Provided by (Used in) Operating Activities for the quarter ending 28 Jun 2025 was $17.4M.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Operating Activities for 2024 was $182M, a 0.01% decline from 2023.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Operating Activities for 2023 was $182M, a 33.4% decline from 2022.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Operating Activities for 2022 was $273M, a 58.5% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

HAEMONETICS CORP Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $17.4M +$44.8M 30 Mar 2025 28 Jun 2025 10-Q 07 Aug 2025
Q2 2024 -$27.4M -$46.5M -244% 31 Mar 2024 29 Jun 2024 10-Q 07 Aug 2025
Q2 2023 $19.1M -$22.9M -54.6% 02 Apr 2023 01 Jul 2023 10-Q 08 Aug 2024
Q2 2022 $42M +$43.7M 03 Apr 2022 02 Jul 2022 10-Q 08 Aug 2023
Q2 2021 -$1.68M -$13.5M -114% 04 Apr 2021 03 Jul 2021 10-Q 10 Aug 2022
Q2 2020 $11.8M +$9.18M +349% 29 Mar 2020 27 Jun 2020 10-Q 11 Aug 2021
Q2 2019 $2.63M -$20.5M -88.6% 31 Mar 2019 29 Jun 2019 10-Q 04 Aug 2020
Q2 2018 $23.1M -$15.3M -39.8% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019
Q2 2017 $38.4M +$7.73M +25.2% 02 Apr 2017 01 Jul 2017 10-Q 07 Aug 2018
Q2 2016 $30.7M +$21.4M +232% 03 Apr 2016 02 Jul 2016 10-Q 07 Aug 2017
Q2 2015 $9.25M -$4.49M -32.7% 29 Mar 2015 27 Jun 2015 10-Q 01 Aug 2016
Q2 2014 $13.7M +$336K +2.51% 30 Mar 2014 28 Jun 2014 10-Q 30 Jul 2015
Q2 2013 $13.4M +$12.8M +2324% 31 Mar 2013 29 Jun 2013 10-Q 31 Jul 2014
Q2 2012 $553K -$26.6M -98% 01 Apr 2012 30 Jun 2012 10-Q 02 Aug 2013
Q2 2011 $27.1M +$13.6M +101% 03 Apr 2011 02 Jul 2011 10-Q 08 Aug 2012
Q2 2010 $13.5M 04 Apr 2010 03 Jul 2010 10-Q 10 Aug 2011

HAEMONETICS CORP Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $182M -$26K -0.01% 31 Mar 2024 29 Mar 2025 10-K 21 May 2025
2023 $182M -$91.3M -33.4% 02 Apr 2023 30 Mar 2024 10-K 21 May 2025
2022 $273M +$101M +58.5% 03 Apr 2022 01 Apr 2023 10-K 21 May 2025
2021 $172M +$63.5M +58.3% 04 Apr 2021 02 Apr 2022 10-K 20 May 2024
2020 $109M -$49.4M -31.2% 29 Mar 2020 03 Apr 2021 10-K 22 May 2023
2019 $158M -$1.06M -0.67% 31 Mar 2019 28 Mar 2020 10-K 25 May 2022
2018 $159M -$61.1M -27.7% 01 Apr 2018 30 Mar 2019 10-K 26 May 2021
2017 $220M +$60.6M +37.9% 02 Apr 2017 31 Mar 2018 10-K 20 May 2020
2016 $160M +$37.9M +31.1% 03 Apr 2016 01 Apr 2017 10-K 22 May 2019
2015 $122M -$5.31M -4.18% 29 Mar 2015 02 Apr 2016 10-K 23 May 2018
2014 $127M -$12.3M -8.85% 30 Mar 2014 28 Mar 2015 10-K 24 May 2017
2013 $140M +$54.5M +64% 31 Mar 2013 29 Mar 2014 10-K 01 Jun 2016
2012 $85.1M -$30.2M -26.2% 01 Apr 2012 30 Mar 2013 10-K 22 May 2015
2011 $115M -$8.14M -6.59% 03 Apr 2011 31 Mar 2012 10-K 22 May 2014
2010 $123M -$7.21M -5.52% 04 Apr 2010 02 Apr 2011 10-K 20 May 2013
2009 $131M 29 Mar 2009 03 Apr 2010 10-K 22 May 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.